Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Bellemain-Appaix

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
European Journal of Heart Failure|May 1, 2020
Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patientsJennifer Cautela, Jean-Michel Tartiere, Alain Cohen-Solal, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 14, 2011
Bleeding complications in primary percutaneous coronary intervention of ST-elevation myocardial infarction in a radial centerOlivier Barthélémy, Johanne Silvain, David Brieger, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 28, 2011
Impact of anticoagulation on ionic and nonionic contrast media effect on thrombogenesis and fibrinolysis: The PEPCIT studyAnne Bellemain-Appaix, Farzin Beygui, Claude Lesty, et al.
JAMA|January 5, 2013
Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysisAnne Bellemain-Appaix, Stephen A O'Connor, Johanne Silvain, et al.
European Journal of Preventive Cardiology|May 22, 2021
Life-threatening and major cardiac events during long-distance races: updates from the prospective RACE PARIS registry with a systematic review and meta-analysisBenoît Gerardin, Paul Guedeney, Anne Bellemain-Appaix, et al.
BMJ (Clinical Research Ed.)|May 9, 2015
Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysisAnne Bellemain-Appaix, Mathieu Kerneis, Stephen A O'Connor, et al.
European Heart Journal|July 2, 2010
Impact of red blood cell transfusion on platelet activation and aggregation in healthy volunteers: results of the TRANSFUSION studyJohanne Silvain, Ana Pena, Guillaume Cayla, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 26, 2010
Heparin or enoxaparin anticoagulation for primary percutaneous coronary interventionDavid Brieger, Jean-Philippe Collet, Johanne Silvain, et al.
Archives of Cardiovascular Diseases|December 14, 2011
One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stentOlivier Barthelemy, Gérard Helft, Johanne Silvain, et al.
European Heart Journal|November 10, 2011
High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET studyJohanne Silvain, Guillaume Cayla, Jean-Sébastien Hulot, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
European Journal of Heart Failure|May 1, 2020
Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patientsJennifer Cautela, Jean-Michel Tartiere, Alain Cohen-Solal, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 14, 2011
Bleeding complications in primary percutaneous coronary intervention of ST-elevation myocardial infarction in a radial centerOlivier Barthélémy, Johanne Silvain, David Brieger, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 28, 2011
Impact of anticoagulation on ionic and nonionic contrast media effect on thrombogenesis and fibrinolysis: The PEPCIT studyAnne Bellemain-Appaix, Farzin Beygui, Claude Lesty, et al.
JAMA|January 5, 2013
Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysisAnne Bellemain-Appaix, Stephen A O'Connor, Johanne Silvain, et al.
European Journal of Preventive Cardiology|May 22, 2021
Life-threatening and major cardiac events during long-distance races: updates from the prospective RACE PARIS registry with a systematic review and meta-analysisBenoît Gerardin, Paul Guedeney, Anne Bellemain-Appaix, et al.
BMJ (Clinical Research Ed.)|May 9, 2015
Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysisAnne Bellemain-Appaix, Mathieu Kerneis, Stephen A O'Connor, et al.
European Heart Journal|July 2, 2010
Impact of red blood cell transfusion on platelet activation and aggregation in healthy volunteers: results of the TRANSFUSION studyJohanne Silvain, Ana Pena, Guillaume Cayla, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 26, 2010
Heparin or enoxaparin anticoagulation for primary percutaneous coronary interventionDavid Brieger, Jean-Philippe Collet, Johanne Silvain, et al.
Archives of Cardiovascular Diseases|December 14, 2011
One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stentOlivier Barthelemy, Gérard Helft, Johanne Silvain, et al.
European Heart Journal|November 10, 2011
High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET studyJohanne Silvain, Guillaume Cayla, Jean-Sébastien Hulot, et al.
Pageof 5